Envarsus xr and Hypomagnesaemia - a phase IV clinical study of FDA data
Summary:
Hypomagnesaemia is reported as a side effect among people who take Envarsus xr (tacrolimus), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Pantoprazole, and have Pyogenic liver abscess.
The phase IV clinical study analyzes which people have Hypomagnesaemia when taking Envarsus xr. It is created by eHealthMe based on reports of 3,807 people who have side effects when taking Envarsus xr from the FDA, and is updated regularly.
What is Envarsus xr?
Envarsus xr has active ingredients of tacrolimus. eHealthMe is studying from 3,819 Envarsus xr users. Check the latest studies of Envarsus xr.
What is Hypomagnesaemia?
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood) is found to be associated with 1,028 drugs and 1,056 conditions by eHealthMe. Check the latest studies of Hypomagnesaemia.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
3,807 people reported to have side effects when taking Envarsus xr.
Among them, 32 people (0.84%) have Hypomagnesaemia.

Among these 32 people:
How long have people been on Envarsus xr when they have Hypomagnesaemia? *
- < 1 month: 75 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 25 %
What is the gender of people who have Hypomagnesaemia when taking Envarsus xr? *
- female: 22.58 %
- male: 77.42 %
What is the age of people who have Hypomagnesaemia when taking Envarsus xr? *
- 0-1: 0.0 %
- 2-9: 3.23 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 9.68 %
- 40-49: 19.35 %
- 50-59: 54.84 %
- 60+: 12.9 %
What are other drugs people take besides Envarsus xr? *
- Pantoprazole: 18 people, 56.25%
- Cellcept: 17 people, 53.12%
- Rimifon: 16 people, 50.00%
- Levofloxacin: 12 people, 37.50%
- Sivextro: 9 people, 28.12%
- Abacavir And Lamivudine: 3 people, 9.38%
- Sofosbuvir: 3 people, 9.38%
- Phytomenadione: 2 people, 6.25%
- Cefazolin: 2 people, 6.25%
- Novorapid: 2 people, 6.25%
What are other side effects people have besides Hypomagnesaemia? *
- Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles): 16 people, 50.00%
- Hypokalemia (low potassium): 5 people, 15.62%
- Hypocalcaemia (levels of calcium in blood serum are abnormally low): 4 people, 12.50%
- Cerebral Atrophy (decrement in size of brain): 3 people, 9.38%
- Hemiplegia (paralysis of one side of the body): 3 people, 9.38%
- Klebsiella Sepsis (klebsiella causes a potentially fatal whole-body inflammation): 3 people, 9.38%
- Posterior Reversible Encephalopathy Syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss): 3 people, 9.38%
- Pyogenic Liver Abscess (liver abscess caused by bacteria): 3 people, 9.38%
- Cerebral Ischaemia (insufficient blood flow to the brain to meet metabolic demand): 3 people, 9.38%
- Klebsiella Infection: 3 people, 9.38%
What are the existing conditions these people have? *
- Latent Tuberculosis (hidden tuberculosis): 16 people, 50.00%
- Pyogenic Liver Abscess (liver abscess caused by bacteria): 16 people, 50.00%
- Immunodeficiency Disorders: 5 people, 15.62%
- Hiv Infection: 3 people, 9.38%
- High Blood Pressure: 3 people, 9.38%
- Pain: 3 people, 9.38%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 9.38%
- Hepatitis C: 3 people, 9.38%
- Dyslipidaemia (abnormal amount of lipids): 2 people, 6.25%
- Haemorrhage (bleeding): 2 people, 6.25%
* Approximation only. Some reports may have incomplete information.
Do you take Envarsus xr and have Hypomagnesaemia?
- Check whether Hypomagnesaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Envarsus xr:
- Envarsus xr (3,819 reports)
Hypomagnesaemia treatments and more:
- Hypomagnesaemia (18,707 reports)
How severe was Hypomagnesaemia and when was it recovered:
Expand to all the drugs that have ingredients of tacrolimus:
- Hypomagnesaemia and drugs with ingredients of tacrolimus (425 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Envarsus xr:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hypomagnesaemia:
- Hypomagnesaemia (1,028 drugs)
Browse all the conditions that are associated with Hypomagnesaemia:
- Hypomagnesaemia (1,056 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on tacrolimus (the active ingredients of Envarsus xr) and Envarsus xr (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Flecainide Acetate cause Pulmonary Oedema Aggravated? - a second ago
- Could Escitalopram cause Lichen Planus? - 2 seconds ago
- Could Allopurinol cause Delirium Tremens? - 4 seconds ago
- Could Clopidogrel Bisulfate cause Speech Impairment (Adult)? - 6 seconds ago
- Avapro and Tamsulosin drug interactions for men aged 50-59 - 20 seconds ago
- Avandamet and Coronary Artery Disease for Men aged 60+ - 32 seconds ago
- Avandamet and Chd for Men aged 60+ - 32 seconds ago
- Avandamet and Cad for Men aged 60+ - 32 seconds ago
- Avandamet and Arteriosclerotic Heart Disease for Men aged 60+ - 33 seconds ago
- Avandamet and Coronary Heart Disease for Men aged 60+ - 33 seconds ago